Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco Northern California utility (NYSE: PCG) ~$22.7B FY2024 revenue; post-2020 bankruptcy, 10K miles undergrounding program, Silicon Valley AI data center load, competing with SCE and SDG&E.
PG&E Corporation is a San Francisco, California-based regulated electric and gas utility holding company — publicly traded on the New York Stock Exchange (NYSE: PCG) as an S&P 500 Utilities component — serving approximately 16 million Californians in a 70,000-square-mile service territory in Northern and Central California through its subsidiary Pacific Gas and Electric Company, providing electric and natural gas service through approximately 27,000 employees. PG&E emerged from Chapter 11 bankruptcy in July 2020 — the largest utility bankruptcy in US history, filed in January 2019 following liability exposure from the 2017 Wine Country fires ($13.5B) and the 2018 Camp Fire ($25.5B), which destroyed the town of Paradise, California, killing 85 people and representing the deadliest California wildfire in history — funding the $13.5 billion wildfire victim trust and implementing the most comprehensive electric utility wildfire safety program in the United States. In fiscal year 2024, PG&E reported revenues of approximately $22.7 billion, with CEO Patti Poppe executing the "Lean" operational transformation: applying manufacturing-industry lean continuous improvement principles to PG&E's grid operations (undergrounding power lines in high wildfire risk areas — targeting 10,000 miles of underground line conversion through 2026), vegetation management (automated trimming tracking and scheduling), and customer operations. The wildfire safety capital investment ($16B+ in the 2023-2026 capital plan for undergrounding, enhanced powerline safety settings, and weather station deployment) enables PG&E to request recovery through California Public Utilities Commission rate cases that translate capital investment into rate base and allowed return.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.